<p>马拉松资本管理在第二季度收购了 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免费报告）的新股份，根据该公司在最近向 SEC 提交的文件。该基金收购了 12,054 股公司股票，价值约为 893,000 美元。</p>
<ul>
<li>GE 航空：卡塔尔交易推动数十亿美元增长引擎</li>
</ul>
<p>其他一些对冲基金和机构投资者最近也买卖了 GEHC 的股票。先锋集团在第二季度将其在 GE HealthCare Technologies 的股份增加了 1.4%。先锋集团目前拥有 52,107,758 股公司股票，价值 3,859,622,000 美元，此前在上个季度又购买了 703,903 股。道奇与考克斯在第二季度将其在 GE HealthCare Technologies 的股份增加了 42.1%。道奇与考克斯目前拥有 23,567,950 股公司股票，价值 1,745,678,000 美元，此前在上个季度又购买了 6,982,441 股。州街公司在第二季度将其在 GE HealthCare Technologies 的持股增加了 1.9%。州街公司目前拥有 19,660,742 股公司股票，价值 1,456,271,000 美元，此前在上个季度又收购了 372,755 股。Geode 资本管理公司在第二季度将其在 GE HealthCare Technologies 的股份增加了 2.0%。Geode 资本管理公司目前拥有 11,944,407 股公司股票，价值 881,060,000 美元，此前在上个季度又收购了 231,302 股。最后，挪威银行在第二季度收购了 GE HealthCare Technologies 的新股份，价值约为 468,120,000 美元。对冲基金和其他机构投资者目前拥有公司 82.06% 的股票。</p>
<h2>GE HealthCare Technologies 股票上涨 1.7%</h2>
<p>GEHC 周四开盘价为 84.47 美元。GE HealthCare Technologies Inc.的 52 周低点为 57.65 美元，52 周高点为 94.80 美元。该公司的债务与股本比率为 0.83，速动比率为 0.95，流动比率为 1.18。该股票的市值为 384.8 亿美元，市盈率为 17.45，PEG 比率为 3.47，贝塔值为 1.10。该公司的 50 日移动平均线为 76.49 美元，200 日移动平均线为 74.79 美元。</p>
<ul>
<li>霍尼韦尔的拆分：HON 股票对投资者来说是个好交易吗？</li>
</ul>
<p>GE HealthCare Technologies（NASDAQ:GEHC - 获取免费报告）最近于 10 月 29 日星期三发布了季度财报。该公司报告每股收益为 1.07 美元，超过分析师一致预期的 1.05 美元，超出 0.02 美元。GE HealthCare Technologies 的股本回报率为 22.52%，净利润率为 10.94%。该公司在本季度的收入为 51.4 亿美元，而分析师预期为 50.7 亿美元。在去年同期，该公司每股收益为 1.14 美元。GE HealthCare Technologies 的季度收入同比增长 5.8%。GE HealthCare Technologies 已将其 2025 财年的指导目标设定为每股收益 4.510-4.630 美元。研究分析师平均预计 GE HealthCare Technologies Inc.今年的每股收益为 4.68 美元。</p>
<h2>GE HealthCare Technologies 宣布分红</h2>
<p>该公司最近还披露了一项季度分红，将于 2 月 13 日星期五支付。1 月 9 日的登记投资者将获得 0.035 美元的分红。这代表着 0.14 美元的年化分红和 0.2% 的收益率。该分红的除息日为 1 月 9 日。GE HealthCare Technologies 的分红支付比率目前为 2.89%。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>超声波减肥：GE HealthCare 与诺和诺德的合作</li>
</ul>
<p>GEHC 最近成为多份分析师报告的主题。华尔街 Zen 在 9 月 20 日星期六的一份研究报告中将 GE HealthCare Technologies 的股票评级从 “买入” 下调至 “持有”。Stifel Nicolaus 在 11 月 21 日星期五的一份研究报告中对 GE HealthCare Technologies 设定了 90.00 美元的目标价。Zacks Research 在 9 月 29 日星期一的一份研究报告中将 GE HealthCare Technologies 的评级从 “强烈买入” 下调至 “持有”。巴克莱在 10 月 13 日星期一的一份研究报告中对 GE HealthCare Technologies 的股票进行了覆盖。他们设定了 “等权重” 评级和 86.00 美元的目标价。最后，摩根士丹利在 10 月 30 日星期四的一份报告中将 GE HealthCare Technologies 的目标价从 74.00 美元上调至 80.00 美元，并给予该股票 “等权重” 评级。六位分析师对该股票给予了买入评级，六位分析师对公司的股票给予了持有评级。根据 MarketBeat 的数据，GE HealthCare Technologies 目前的共识评级为 “适度买入”，共识目标价为 86.45 美元。</p>
<p><strong>获取我们关于 GE HealthCare Technologies 的最新报告</strong></p>
<h2>GE HealthCare Technologies 公司简介</h2>
<p>（免费报告）</p>
<p>GE HealthCare Technologies Inc.从事产品、服务和补充数字解决方案的开发、制造和营销，这些产品、服务和解决方案用于美国、加拿大及国际上患者的诊断、治疗和监测。该公司通过四个部门运营：成像、超声、患者护理解决方案和药物诊断。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 GE HealthCare Technologies 更好</li>
<li>S&amp;P/TSX 指数是什么？</li>
<li>GameStop 看起来崩溃：为什么 GME 可能在 2026 年崩盘</li>
<li>经济报告在成功投资策略中的作用</li>
<li>市场动量：3 只有望大幅突破的股票</li>
<li>现在购买的 3 只巨型成长股</li>
<li>3 个理由说明 Casey’s General Stores 将继续上涨</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 GE HealthCare Technologies 吗？</h2>
<p>在考虑 GE HealthCare Technologies 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 GE HealthCare Technologies 并不在名单上。</p>
<p>虽然 GE HealthCare Technologies 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

GEHC

<p>马拉松资本管理公司收购了 12,054 股 GE HealthCare Technologies，价值 89.3 万美元。其他机构投资者也增加了他们的持仓。GEHC 的股票开盘价为 84.47 美元，市值为 384.8 亿美元。分析师的评级不一，有些将评级下调至 “持有”，而其他则将目标价设定在 80 至 90 美元之间。GEHC 报告的季度每股收益为 1.07 美元，超出预期，并宣布每股派息 0.035 美元</p>

<p>Marathon Capital Management acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 12,054 shares of the company's stock, valued at approximately $893,000.</p>
<div class="lb-trans"><p>马拉松资本管理在第二季度收购了 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免费报告）的新股份，根据该公司在最近向 SEC 提交的文件。该基金收购了 12,054 股公司股票，价值约为 893,000 美元。</p>
</div><ul>
<li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li>
</ul>
<div class="lb-trans"><ul>
<li>GE 航空：卡塔尔交易推动数十亿美元增长引擎</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors also recently bought and sold shares of GEHC. Vanguard Group Inc. increased its position in shares of GE HealthCare Technologies by 1.4% during the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company's stock worth $3,859,622,000 after purchasing an additional 703,903 shares in the last quarter. Dodge &amp; Cox increased its position in GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge &amp; Cox now owns 23,567,950 shares of the company's stock valued at $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter. State Street Corp boosted its holdings in GE HealthCare Technologies by 1.9% in the second quarter. State Street Corp now owns 19,660,742 shares of the company's stock worth $1,456,271,000 after acquiring an additional 372,755 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 2.0% during the second quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company's stock worth $881,060,000 after acquiring an additional 231,302 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of GE HealthCare Technologies during the second quarter valued at about $468,120,000. Hedge funds and other institutional investors own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者最近也买卖了 GEHC 的股票。先锋集团在第二季度将其在 GE HealthCare Technologies 的股份增加了 1.4%。先锋集团目前拥有 52,107,758 股公司股票，价值 3,859,622,000 美元，此前在上个季度又购买了 703,903 股。道奇与考克斯在第二季度将其在 GE HealthCare Technologies 的股份增加了 42.1%。道奇与考克斯目前拥有 23,567,950 股公司股票，价值 1,745,678,000 美元，此前在上个季度又购买了 6,982,441 股。州街公司在第二季度将其在 GE HealthCare Technologies 的持股增加了 1.9%。州街公司目前拥有 19,660,742 股公司股票，价值 1,456,271,000 美元，此前在上个季度又收购了 372,755 股。Geode 资本管理公司在第二季度将其在 GE HealthCare Technologies 的股份增加了 2.0%。Geode 资本管理公司目前拥有 11,944,407 股公司股票，价值 881,060,000 美元，此前在上个季度又收购了 231,302 股。最后，挪威银行在第二季度收购了 GE HealthCare Technologies 的新股份，价值约为 468,120,000 美元。对冲基金和其他机构投资者目前拥有公司 82.06% 的股票。</p>
</div><h2>GE HealthCare Technologies Stock Up 1.7%</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 股票上涨 1.7%</h2>
</div><p>GEHC opened at $84.47 on Thursday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The stock has a market capitalization of $38.48 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 3.47 and a beta of 1.10. The company has a fifty day moving average of $76.49 and a two-hundred day moving average of $74.79.</p>
<div class="lb-trans"><p>GEHC 周四开盘价为 84.47 美元。GE HealthCare Technologies Inc.的 52 周低点为 57.65 美元，52 周高点为 94.80 美元。该公司的债务与股本比率为 0.83，速动比率为 0.95，流动比率为 1.18。该股票的市值为 384.8 亿美元，市盈率为 17.45，PEG 比率为 3.47，贝塔值为 1.10。该公司的 50 日移动平均线为 76.49 美元，200 日移动平均线为 74.79 美元。</p>
</div><ul>
<li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>霍尼韦尔的拆分：HON 股票对投资者来说是个好交易吗？</li>
</ul>
</div><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion during the quarter, compared to analysts' expectations of $5.07 billion. During the same quarter in the prior year, the firm posted $1.14 EPS. GE HealthCare Technologies's quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.</p>
<div class="lb-trans"><p>GE HealthCare Technologies（NASDAQ:GEHC - 获取免费报告）最近于 10 月 29 日星期三发布了季度财报。该公司报告每股收益为 1.07 美元，超过分析师一致预期的 1.05 美元，超出 0.02 美元。GE HealthCare Technologies 的股本回报率为 22.52%，净利润率为 10.94%。该公司在本季度的收入为 51.4 亿美元，而分析师预期为 50.7 亿美元。在去年同期，该公司每股收益为 1.14 美元。GE HealthCare Technologies 的季度收入同比增长 5.8%。GE HealthCare Technologies 已将其 2025 财年的指导目标设定为每股收益 4.510-4.630 美元。研究分析师平均预计 GE HealthCare Technologies Inc.今年的每股收益为 4.68 美元。</p>
</div><h2>GE HealthCare Technologies Announces Dividend</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 宣布分红</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies's dividend payout ratio is currently 2.89%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度分红，将于 2 月 13 日星期五支付。1 月 9 日的登记投资者将获得 0.035 美元的分红。这代表着 0.14 美元的年化分红和 0.2% 的收益率。该分红的除息日为 1 月 9 日。GE HealthCare Technologies 的分红支付比率目前为 2.89%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li>
</ul>
<div class="lb-trans"><ul>
<li>超声波减肥：GE HealthCare 与诺和诺德的合作</li>
</ul>
</div><p>GEHC has been the subject of a number of recent analyst reports. Wall Street Zen cut shares of GE HealthCare Technologies from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, September 20th. Stifel Nicolaus set a $90.00 price target on GE HealthCare Technologies in a research note on Friday, November 21st. Zacks Research lowered GE HealthCare Technologies from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, September 29th. Barclays initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They set an &#34;equal weight&#34; rating and a $86.00 price objective for the company. Finally, Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an &#34;equal weight&#34; rating in a report on Thursday, October 30th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $86.45.</p>
<div class="lb-trans"><p>GEHC 最近成为多份分析师报告的主题。华尔街 Zen 在 9 月 20 日星期六的一份研究报告中将 GE HealthCare Technologies 的股票评级从 “买入” 下调至 “持有”。Stifel Nicolaus 在 11 月 21 日星期五的一份研究报告中对 GE HealthCare Technologies 设定了 90.00 美元的目标价。Zacks Research 在 9 月 29 日星期一的一份研究报告中将 GE HealthCare Technologies 的评级从 “强烈买入” 下调至 “持有”。巴克莱在 10 月 13 日星期一的一份研究报告中对 GE HealthCare Technologies 的股票进行了覆盖。他们设定了 “等权重” 评级和 86.00 美元的目标价。最后，摩根士丹利在 10 月 30 日星期四的一份报告中将 GE HealthCare Technologies 的目标价从 74.00 美元上调至 80.00 美元，并给予该股票 “等权重” 评级。六位分析师对该股票给予了买入评级，六位分析师对公司的股票给予了持有评级。根据 MarketBeat 的数据，GE HealthCare Technologies 目前的共识评级为 “适度买入”，共识目标价为 86.45 美元。</p>
</div><p><strong>Get Our Latest Report on GE HealthCare Technologies</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 GE HealthCare Technologies 的最新报告</strong></p>
</div><h2>GE HealthCare Technologies Company Profile</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.</p>
<div class="lb-trans"><p>GE HealthCare Technologies Inc.从事产品、服务和补充数字解决方案的开发、制造和营销，这些产品、服务和解决方案用于美国、加拿大及国际上患者的诊断、治疗和监测。该公司通过四个部门运营：成像、超声、患者护理解决方案和药物诊断。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than GE HealthCare Technologies</li>
<li>What is the S&amp;P/TSX Index?</li>
<li>GameStop Looks Broken: Here’s Why GME Could Crash in 2026</li>
<li>The Role Economic Reports Play in a Successful Investment Strategy</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>3 Monster Growth Stocks to Buy Now</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 GE HealthCare Technologies 更好</li>
<li>S&amp;P/TSX 指数是什么？</li>
<li>GameStop 看起来崩溃：为什么 GME 可能在 2026 年崩盘</li>
<li>经济报告在成功投资策略中的作用</li>
<li>市场动量：3 只有望大幅突破的股票</li>
<li>现在购买的 3 只巨型成长股</li>
<li>3 个理由说明 Casey’s General Stores 将继续上涨</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=GEHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 GE HealthCare Technologies 吗？</h2>
</div><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 GE HealthCare Technologies 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 GE HealthCare Technologies 并不在名单上。</p>
</div><p>While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 GE HealthCare Technologies 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

马拉松资本管理公司在 GE HealthCare Technologies Inc.（GE HealthCare Tech）中建立了头寸